Alzheimer's Society's flagship Drug Discovery programme is a new approach to developing treatments for dementia. To explain how the programme works the Alzheimer's Society have created a short Drug Discovery video.
Drug Discovery Programme - Alzheimer's Society Dementia Research
Neurologist and author Oliver Sacks brings our attention to Charles Bonnett syndrome -- when visually impaired people experience lucid hallucinations. He describes the experiences of his patients in heartwarming detail and walks us through the biology of this under-reported phenomenon.WATCH NOW